South Korea Oncology Clinical Trials Market Analysis

South Korea Oncology Clinical Trials Market Analysis

$ 3999

South Korea's oncology clinical trials market is projected to grow from $184.8 Mn in 2022 to $305.9 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the country's well-established infrastructure, advanced medical facilities, and streamlined regulatory processes. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc., Roche Holding AG & SK Biopharmaceuticals.

ID: IN10KRCT006 CATEGORY: Clinical Trials GEOGRAPHY: South Korea AUTHOR: Vidhi Upadhyay

Buy Now

South Korea Oncology Clinical Trials Market Executive Summary

The South Korea Oncology Clinical Trials Market is projected to grow from $184.8 Mn in 2022 to $305.9 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. South Korea had 799 registered clinical studies for medicinal treatments in 2020, 432 of which were regional trials and the rest were international trials. During the previous year, the number of both regional and international trials increased. In 2022, Korea is anticipated to have 274,488 new cancer cases and 81,277 cancer deaths. The thyroid was predicted to be the most prevalent cancer location, followed by the lung, colon and rectum, breast, and stomach. These five malignancies were predicted to account for half of the total cancer burden in Korea. Lung cancer was predicted to be the most prevalent cause of death, followed by liver, colorectal, pancreatic, and gallbladder cancers.

South Korea is a fast-expanding nation that has achieved substantial advances in medical research, particularly clinical trials for cancer. The country has several hospitals and research organizations such as National Cancer Center, Seoul National University Hospital, Samsung Medical Center & Korea Cancer Center which highly qualified medical workers make it an appealing location for clinical trials. The efficiency with which oncology clinical trials may be performed in South Korea is one of their most prominent features. The nation has a simplified regulatory framework that enables clinical studies to be approved more quickly, and it also has a huge pool of patients ready to participate in these trials. South Korea is a great place for conducting oncology clinical trials due to its well-developed infrastructure, quick regulatory procedure, and highly competent medical staff. As a result, the nation is anticipated to continue to play a prominent role in worldwide research and development of novel cancer therapies.

south korea oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

The country's well-established infrastructure and excellent medical facilities, which offer a great setting for conducting clinical trials, are significant development drivers. Moreover, the nation boasts highly competent medical personnel, including experienced oncologists and clinical researchers. Another important growth driver for oncology clinical trials in South Korea is the country's simplified regulatory procedure, which enables for clinical studies to be approved more quickly. This regulatory climate has made it simpler for foreign pharmaceutical corporations to perform clinical trials in the country, leading to a rise in the number of studies. South Korea also has a big number of patients eager to take part in clinical studies. The nation has a strong medical research culture, and patients are typically eager to contribute to the development of novel cancer cures and therapeutics.

Market Restraints

In South Korea, there are also certain limitations to the oncology clinical trials market expansion. Competition from other nations, such as China and India, who are also quickly increasing their medical research infrastructure and regulatory systems, is one of the most significant ones. Moreover, due to the country's tiny population and restricted geographic region, it may be difficult to recruit enough individuals for some kinds of clinical studies. Lastly, some people are concerned about the possibility of conflicts of interest between researchers and pharmaceutical corporations that fund clinical studies.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • SK Biopharmaceuticals (KOR)
  • Genexine (KOR)

Notable Insights

  1. November 2022, SK Biopharmaceuticals, based in South Korea, announced that the state-run Korea Drug Development Fund (KDDF) decided to support and fund the company's development of SKL27969, which is being evaluated as a possible therapy for patients with advanced solid tumors, expanding SK Biopharmaceuticals' area of expertise into oncology
  2. August 2022, Genexine, a publicly traded, clinical-staged Korean biopharmaceutical company, revealed that the first patient in a phase 2 clinical trial using triple combination therapy in patients with recurrent/metastatic HNSCC has been dosed
  3. April 2022, Tucatinib, a breast cancer therapy, has been approved for phase 3 clinical trials in South Korea. Tucatinib is an oral breast cancer therapy developed by Seattle Genetics

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 24 March 2023
Updated by: Anish Swaminathan

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter